A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
Study Identifier
M17-377
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Plain Language Summary
Available Language(s): English, Japanese
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
12 - 75 Years
Protocol Summary
The objective of this study is to assess the safety of upadacitinib combined with topical corticosteroids (TCS) in adolescent and adult participants in Japan with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.
Study Locations
Location
Status
Location
Ichinomiya Municipal Hospital /ID# 205942
Ichinomiya-shi, Aichi-ken, Japan, 491-8558
Status
Not applicable
Location
Central Clinic /ID# 206558
Nagoya, Aichi-ken, Japan, 464-0821
Status
Not applicable
Location
Nagoya City University Hospital /ID# 207566
Nagoya, Aichi-ken, Japan, 467-8602
Status
Not applicable
Location
Yasumoto Dermatology Clinic /ID# 206480
Chikushino-shi, Fukuoka, Japan, 818-0083
Status
Not applicable
Location
Kiryu Dermatology Clinic /ID# 206044
Fukuoka, Fukuoka, Japan, 813-0044
Status
Not applicable
Location
Medical Corporation Matsuo Clinic /ID# 207323
Fukuoka, Fukuoka, Japan, 819-0373
Status
Not applicable
Showing {first} - {last} of {total} Results